Connect with others who understand.

sign up log in
About MyMSTeam

COVID-19 and Multiple Sclerosis (MS) Essential Updates

Updated on September 24, 2021

During the COVID-19 pandemic, MyMSTeam will provide summaries and links to articles of importance to people living with multiple sclerosis (MS). This page will be updated with information as it becomes available.

  • Join the conversation about COVID-19 and MS by commenting below.

Are People With MS Eligible for Moderna and Johnson & Johnson Booster Shots?

MyMSTeam, October 26, 2021

Read the full article here.

CDC Releases New COVID-19 Vaccine Booster Guidelines

MyMSTeam, September 24, 2021

The Centers for Disease Control and Prevention (CDC) recommended Pfizer COVID-19 vaccine booster shots for adults over 65 and other high-risk individuals. If you are on multiple sclerosis (MS) treatment, consult with your health care provider before presenting for a booster shot, since some MS treatments should be timed around vaccinations.

Read the full article here.

MS and COVID-19 Vaccines: Q&A With Dr. Barry Singer

MyMSTeam, February 10, 2021

In January, the Multiple Sclerosis Coalition issued guidance, echoed by the National Multiple Sclerosis Society, recommending that everyone with MS receive the Pfizer-BioNTech or Moderna COVID-19 vaccine as early as possible. MyMSTeam members still have many questions about COVID-19 vaccines. MyMSTeam invited Dr. Barry Singer to help us address these questions.

Read the full article here.

MS Treatments and COVID-19: What to Discuss With Your Neurologist

MyMSTeam, August 4, 2020

Key Takeaways

  • According to Dr. Aaron Boster of the The Boster Center for Multiple Sclerosis, people with MS are not at greater risk of contracting COVID-19. It is important to practice social distancing and frequent hand-washing, and to wear a mask in public.
  • Some MS treatments may suppress the immune system and put people at risk for a more serious infection, if they contract COVID-19. Talk with your doctor about the best course of treatment for you.
  • It is crucial to stay in communication with your neurologist during this time. Be sure to contact your doctor before starting or stopping any new treatments, if you experience an MS flare-up or a treatment delay, and if you test positive for COVID-19.

Read the full article here.

Canceling Is Kindness: Keeping Safe From COVID-19 With Multiple Sclerosis

MyMSTeam, March 20, 2020

Key Takeaways

  • Remind loved ones of the seriousness of your situation. According to research in China, people who had one additional disease had a 79 percent higher risk of requiring intensive care, needing a respirator, or dying as a result of COVID-19.
  • If there are others in your circle who take the threat seriously, ask them to talk to your loved one on your behalf.
  • Suggest ways to stay socially connected from a safe distance.

Read the full article here.

Other COVID-19 Resources

Recent articles

Multiple sclerosis (MS) is an autoimmune disease that targets the myelin sheath (fatty coating)...

Secondhand Smoke in Childhood: Does It Raise the Risk for Multiple Sclerosis?

Multiple sclerosis (MS) is an autoimmune disease that targets the myelin sheath (fatty coating)...
Being diagnosed with multiple sclerosis (MS) is a life-changing event that can alter the way you...

Medical Power of Attorney and Multiple Sclerosis

Being diagnosed with multiple sclerosis (MS) is a life-changing event that can alter the way you...
Highly effective (HE) disease-modifying treatments (DMTs) can help slow progression of multiple...

What Is Highly Effective Treatment for MS?

Highly effective (HE) disease-modifying treatments (DMTs) can help slow progression of multiple...
In recent years, neurologists have discussed how to set goals for treating relapsing-remitting...

Quiz: What Are Your MS Treatment Goals?

In recent years, neurologists have discussed how to set goals for treating relapsing-remitting...
Doctors measure the effectiveness of disease-modifying therapies (DMTs) in multiple sclerosis...

MS Treatment: How Is Effectiveness Measured?

Doctors measure the effectiveness of disease-modifying therapies (DMTs) in multiple sclerosis...
Switching disease-modifying therapies (DMTs) is common among people who are treating relapsing...

Switching MS Treatments: When and Why It Might Be Time To Switch

Switching disease-modifying therapies (DMTs) is common among people who are treating relapsing...
Approximately 40 percent to 65 percent of individuals with multiple sclerosis (MS) live with...

Cognitive Rehabilitation for Multiple Sclerosis: How Can It Help?

Approximately 40 percent to 65 percent of individuals with multiple sclerosis (MS) live with...
Brain fog or “cog fog” are names for cognitive symptoms that occur in about half of people with...

Brain Fog and Multiple Sclerosis

Brain fog or “cog fog” are names for cognitive symptoms that occur in about half of people with...
Roughly 40 percent to 65 percent of people living with multiple sclerosis (MS) have some form of...

Multiple Sclerosis and Cognition: What To Watch For

Roughly 40 percent to 65 percent of people living with multiple sclerosis (MS) have some form of...
Cognitive symptoms such as impaired attention and memory occur in many people with multiple...

Strategies for Enhancing Cognitive Abilities With Multiple Sclerosis

Cognitive symptoms such as impaired attention and memory occur in many people with multiple...
MyMSTeam My multiple sclerosis Team

Thank you for signing up.

close